GlassScriptPhysician profile
Dmitriy Rybitskiy
NPI 1275896508
$13,444.12
in general payments reported to CMS, 2019-2025
48 companies · $1,619 in 2025
The $1,619 reported for 2025 was more than what 77% of Surgical Critical Care providers received nationally (typical 2025 total: $234).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,442 · 2020: $2,973 · 2021: $1,021 · 2022: $1,354 · 2023: $343 · 2024: $3,692 · 2025: $1,619.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $2,500 · Food and Beverage: $1,961 · Travel and Lodging: $1,193.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $2,500.00 |
| Food and Beverage | $1,961.34 |
| Travel and Lodging | $1,192.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,451.76 | 2021-2024 | |
| Medtronic Vascular, INC. | $1,179.96 | 2019-2020 | |
| Solventum Corporation | $1,018.02 | 2025 | 3m Cavilon, Prevena, V.A.C. Veraflo |
| Silk Road Medical, INC. | $1,001.63 | 2019 | |
| Bolton Medical INC | $979.25 | 2019-2021 | |
| Centinel Spine, LLC | $976.86 | 2020 | |
| Medical Device Business Services, INC. | $803.22 | 2022 | |
| Endologix LLC | $615.18 | 2019-2022 | |
| Davol INC. | $381.86 | 2024-2025 | Phasix Mesh |
| Penumbra, INC. | $273.63 | 2020-2024 | Indigo System |
| Angiodynamics, INC. | $254.49 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $251.73 | 2019-2021 | |
| Depuy Synthes Sales INC. | $228.31 | 2022 | |
| Boston Scientific Corporation | $154.87 | 2025 | Spyglass Discover, Enroute Transcarotid Neuroprotection System |
| W. L. Gore & Associates, INC. | $132.70 | 2022-2025 | Gore Synecor Preperitoneal Biomaterial |
Show all 48 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $119.03 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $118.70 | 2019 | |
| Csl Behring | $114.69 | 2022-2023 | Kcentra, Berinert |
| Getinge USA Sales, LLC | $107.26 | 2019-2021 | |
| Innovation Technologies INC | $105.49 | 2025 | Irrisept |
| Shionogi INC | $91.09 | 2023 | Fetroja |
| Bard Peripheral Vascular, INC. | $89.67 | 2021 | |
| Inari Medical, INC. | $89.66 | 2021 | |
| Access Pro Medical, LLC | $89.42 | 2023 | Matriderm |
| Integra Lifesciences Corporation | $83.16 | 2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Baudax Bio INC. | $77.00 | 2021 | |
| Teleflex LLC | $70.21 | 2020-2022 | |
| Elutia, INC. | $61.77 | 2019 | |
| Cook Medical LLC | $54.32 | 2020-2022 | |
| Zimmer Biomet Holdings, INC. | $51.43 | 2024 | Avenir |
| Acell, INC. | $45.35 | 2020 | |
| Atricure, INC. | $37.51 | 2023 | |
| Tactile Systems Technology INC | $35.22 | 2019-2021 | |
| Acera Surgical, INC. | $31.80 | 2025 | Restrata Wound Matrix |
| Takeda Pharmaceuticals U.S.A., INC. | $27.28 | 2023 | Entyvio |
| Humacyte Global, INC. | $26.19 | 2025 | Symvess |
| Ethicon US, LLC | $22.61 | 2023 | Echelon Endopath, Enseal X1, Echelon Circular |
| Cardiovascular Systems INC. | $22.20 | 2020 | |
| Mozarc Medical US LLC | $21.50 | 2025 | Chameleon |
| Haemonetics Corporation | $20.23 | 2024 | Teg6s Hemostasis System |
| Merck Sharp & Dohme LLC | $19.08 | 2022 | |
| Cardinal Health 200 LLC | $17.49 | 2020 | |
| Abbvie INC. | $16.10 | 2023 | Humira, Rinvoq |
| Pfizer INC. | $16.05 | 2022 | |
| Convatec INC. | $15.59 | 2021 | |
| Smith+Nephew, INC. | $14.91 | 2024 | Collagenase Santyl |
| Baxter Healthcare | $14.45 | 2021 | |
| Cumberland Pharmaceuticals, INC. | $14.19 | 2024 | Caldolor |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dmitriy Rybitskiy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.